首页> 外文OA文献 >Structure of human phytanoyl-CoA 2-hydroxylase identifies molecular mechanisms of Refsum disease.
【2h】

Structure of human phytanoyl-CoA 2-hydroxylase identifies molecular mechanisms of Refsum disease.

机译:人植酸酰辅酶A 2-羟化酶的结构确定了Refsum疾病的分子机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Refsum disease (RD), a neurological syndrome characterized by adult onset retinitis pigmentosa, anosmia, sensory neuropathy, and phytanic acidaemia, is caused by elevated levels of phytanic acid. Many cases of RD are associated with mutations in phytanoyl-CoA 2-hydroxylase (PAHX), an Fe(II) and 2-oxoglutarate (2OG)-dependent oxygenase that catalyzes the initial alpha-oxidation step in the degradation of phytenic acid in peroxisomes. We describe the x-ray crystallographic structure of PAHX to 2.5 A resolution complexed with Fe(II) and 2OG and predict the molecular consequences of mutations causing RD. Like other 2OG oxygenases, PAHX possesses a double-stranded beta-helix core, which supports three iron binding ligands (His(175), Asp(177), and His(264)); the 2-oxoacid group of 2OG binds to the Fe(II) in a bidentate manner. The manner in which PAHX binds to Fe(II) and 2OG together with the presence of a cysteine residue (Cys(191)) 6.7 A from the Fe(II) and two further histidine residues (His(155) and His(281)) at its active site distinguishes it from that of the other human 2OG oxygenase for which structures are available, factor inhibiting hypoxia-inducible factor. Of the 15 PAHX residues observed to be mutated in RD patients, 11 cluster in two distinct groups around the Fe(II) (Pro(173), His(175), Gln(176), Asp(177), and His(220)) and 2OG binding sites (Trp(193), Glu(197), Ile(199), Gly(204), Asn(269), and Arg(275)). PAHX may be the first of a new subfamily of coenzyme A-binding 2OG oxygenases.
机译:Refsum疾病(RD)是一种神经系统综合征,其特征是成人发作性色素性视网膜炎,失眠,感觉神经病和植酸性贫血,是由植酸水平升高引起的。 RD的许多病例与植酸酰辅酶A 2-羟化酶(PAHX),Fe(II)和2-氧代戊二酸(2OG)依赖性加氧酶中的突变有关,该酶催化过氧化物酶体中植酸的降解中的初始α-氧化步骤。 。我们描述了PAHX的X射线晶体学结构,使其具有与Fe(II)和2OG结合的2.5 A分辨率,并预测了引起RD的突变的分子后果。像其他2OG加氧酶一样,PAHX具有双链β-螺旋核心,该核心支持三个铁结合配体(His(175),Asp(177)和His(264)); 2OG的2-含氧酸基团以二齿方式与Fe(II)结合。 PAHX与Fe(II)和2OG结合的方式以及来自Fe(II)的半胱氨酸残基(Cys(191))6.7 A和另外两个组氨酸残基(His(155)和His(281))的结合方式)在其活性位点上与其他人类2OG加氧酶(结构可用)不同,后者是抑制缺氧诱导因子的因子。在RD患者中观察到的15个PAHX残基中,有11个在Fe(II)(Pro(173),His(175),Gln(176),Asp(177)和His(220)周围两个不同的组中聚集)和2OG结合位点(Trp(193),Glu(197),Ile(199),Gly(204),Asn(269)和Arg(275))。 PAHX可能是辅酶A结合2OG加氧酶的一个新的亚家族中的第一个。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号